| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 900.54 | 902.09 | 616.59 | 562.44 |
Depreciation | -120.96 | -111.49 | -91.29 | -57.14 |
Tax paid | -180.68 | -226.45 | -171.54 | -134.92 |
Working capital | 278.87 | 306.22 | 272.08 | 231.17 |
Other operating items | ||||
Operating | 877.77 | 870.37 | 625.84 | 601.55 |
Capital expenditure | 76.63 | 159.89 | 547.27 | 536.03 |
Free cash flow | 954.41 | 1,030.26 | 1,173.11 | 1,137.58 |
Equity raised | 5,381.73 | 4,718.46 | 4,029.73 | 2,972.54 |
Investing | 7.97 | 71.11 | -114.87 | 1.81 |
Financing | 46.4 | 49.4 | 23.49 | 0 |
Dividends paid | 82.21 | 82.9 | 113.44 | 0 |
Net in cash | 6,472.72 | 5,952.13 | 5,224.9 | 4,111.94 |
Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
